Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?

19 Dec 2014

Abstract excerpt

Drug bioavailability may vary greatly amongst individuals, affecting both efficacy and toxicity: in humans, genetic variations account for a relevant proportion of such variability. In the last decade the use of pharmacogenetics in clinical practice, as a tool to individualize treatment, has shown a different degree of diffusion in various clinical fields. In the field of infectious diseases, several studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Drug Transport and Resistance Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24909419
DOI: 10.2174/1389200215666140605130935

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?PMID 24909419Read ↗

Pharmacogenomics of AntibioticsSemantic proximity Read ↗

Can pharmacokinetic-pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?Semantic proximity Read ↗

Antibiotic resistance--what's dosing got to do with it?Semantic proximity Read ↗

Pharmacogenomics of antimicrobial agents.Semantic proximity Read ↗

Antibiotic Development and the Evolving Role of Pharmacodynamics - As Good as It Gets?Semantic proximity Read ↗

[Proper antibiotic therapy. From penicillin to pharmacogenomic].Semantic proximity Read ↗

Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parametersSemantic proximity Read ↗

[Pharmacodynamic and pharmacokinetic evaluation of respiratory fluoroquinolones. Guideline to selection of the most appropriate fluoroquinolone].Semantic proximity Read ↗

Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.Semantic proximity Read ↗

Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin. SPILF.).Semantic proximity Read ↗

Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populationsSemantic proximity Read ↗

Interpersonal Factors in the Pharmacokinetics and Pharmacodynamics of Voriconazole: Are CYP2C19 Genotypes Enough for Us to Make a Clinical Decision?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.